Evidence map›Paper›PMID 25876153›Full record

ArticlePloS one2015

Immune activation efficacy of indolicidin is enhanced upon conjugation with carbon nanotubes and gold nanoparticles.

Abhinav Sur, Biswaranjan Pradhan, Arka Banerjee, Palok Aich

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 42 citations in OpenAlex.

  1. Nanosystems for delivery of indolicidin peptide.Frontiers in medical technology · 2026
    Review
  2. Nanomaterials and Their Impact on the Immune System.International journal of molecular sciences · 2023
    Review
  3. Review
  4. Rediscovery of antimicrobial peptides as therapeutic agents.Journal of microbiology (Seoul, Korea) · 2021
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Potential applications of nanoparticles in cancer immunotherapy.Human vaccines & immunotherapeutics · 2017
    Review
  13. Article
  14. Nanoparticles and direct immunosuppression.Experimental biology and medicine (Maywood, N.J.) · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Abhinav SurSchool of Biological Sciences, National Institute of Science Education and Research, Bhubaneswar, India.
Biswaranjan PradhanSchool of Biological Sciences, National Institute of Science Education and Research, Bhubaneswar, India.
Arka BanerjeeSchool of Biological Sciences, National Institute of Science Education and Research, Bhubaneswar, India.
Palok AichSchool of Biological Sciences, National Institute of Science Education and Research, Bhubaneswar, India.
National Institute of Science Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotic resistance is concern of today's world. Search for alternative molecules, for treatment and immune stimulation, remains at the forefront. One such group of biomolecules with promise, along the line of immune stimulation or therapy, is host defense peptide (HDP). These molecules, however, are required at a higher dose to be effective which leads to high cost. To alleviate such problems, an aid can be used to achieve similar efficacy but at a smaller effective dose of the immune stimulant. We hypothesised that by conjugating HDPs with carbon nanotubes and/or gold nanoparticles, it would be possible to stimulate a protective immune response in host system at a lower dosage of HDP. In this report, we characterized, using biophysical methodologies, conjugation of Indolicidin, as a representative of HDP. We further established efficacy of peptide-nanomaterial conjugates in activating innate immunity and protecting against pathogen infection in vitro at a significantly small dose.

Indexed as

AnimalsAnti-Infective AgentsAntimicrobial Cationic PeptidesCell LineCell Line, TumorCell SurvivalCytokinesGene ExpressionGoldHost-Pathogen InteractionsHumansImmunity, InnateMacrophagesMetal NanoparticlesMiceMicroscopy, Electron, ScanningAnti-Infective AgentsAntimicrobial Cationic PeptidesCytokinesGoldindolicidinNanotubes, CarbonNF-kappa B

Identifiers

PMID25876153
PMCPMC4398554
OpenAlexW2037135629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.